Wall Street Experts
ver. ZuMIgo(08/25)
Eton Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 35
EBIT TTM (mln): -5
| index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
| Rok finansowy |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
| Przychód (mln) |
0 |
0 |
1 |
0 |
22 |
21 |
32 |
39 |
| Przychód Δ r/r |
0.0% |
0.0% |
inf% |
-95.9% |
55879.5% |
-2.7% |
48.9% |
23.3% |
| Marża brutto |
-inf% |
0.0% |
52.8% |
-633.3% |
88.0% |
67.4% |
66.6% |
60.0% |
| EBIT (mln) |
-7 |
-10 |
-19 |
-27 |
-1 |
-8 |
-1 |
-3 |
| EBIT Δ r/r |
0.0% |
44.3% |
80.2% |
45.8% |
-94.5% |
452.5% |
-85.6% |
117.9% |
| EBIT (%) |
0.0% |
0.0% |
-1939.6% |
-69515.4% |
-6.8% |
-38.9% |
-3.8% |
-6.7% |
| Koszty finansowe (mln) |
0 |
0 |
0 |
-1 |
1 |
-1 |
0 |
0 |
| EBITDA (mln) |
-7 |
-8 |
-18 |
-26 |
-1 |
-6 |
-0 |
-3 |
| EBITDA(%) |
0.0% |
0.0% |
-1893.0% |
-67846.2% |
-4.7% |
-30.5% |
-0.9% |
-6.7% |
| Podatek (mln) |
0 |
-3 |
-0 |
1 |
1 |
1 |
0 |
0 |
| Zysk Netto (mln) |
-7 |
-13 |
-18 |
-29 |
-3 |
-10 |
-1 |
-4 |
| Zysk netto Δ r/r |
0.0% |
78.0% |
41.6% |
59.8% |
-89.7% |
230.4% |
-90.4% |
308.4% |
| Zysk netto (%) |
0.0% |
0.0% |
-1881.0% |
-73920.5% |
-13.6% |
-46.0% |
-3.0% |
-9.8% |
| EPS |
-0.41 |
-1.99 |
-1.02 |
-1.37 |
-0.12 |
-0.39 |
-0.0365 |
-0.15 |
| EPS (rozwodnione) |
-0.41 |
-1.99 |
-1.02 |
-1.37 |
-0.12 |
-0.39 |
-0.0365 |
-0.15 |
| Ilośc akcji (mln) |
17 |
6 |
18 |
21 |
25 |
25 |
26 |
26 |
| Ważona ilośc akcji (mln) |
17 |
6 |
18 |
21 |
25 |
25 |
26 |
26 |
| Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |